Xuewen Wang, Qiqi Cao, Tao Liu, Fan Zhang, Shujuan Zhang, Shaobo Shi, Qingyan Zhao, He Huang, Congxin Huang
{"title":"年轻房颤患者导管消融的临床特点和结果","authors":"Xuewen Wang, Qiqi Cao, Tao Liu, Fan Zhang, Shujuan Zhang, Shaobo Shi, Qingyan Zhao, He Huang, Congxin Huang","doi":"10.1002/clc.70144","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Data concerning young patients with atrial fibrillation (AF) are currently limited.</p>\n </section>\n \n <section>\n \n <h3> Hypothesis</h3>\n \n <p>This study aimed to assess the clinical characteristics and risk factors for AF recurrence in young patients following catheter ablation (CA).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>All AF patients aged ≤ 45 years who underwent CA were identified from the China Atrial Fibrillation Center database between September 2018 and September 2023. Baseline clinical characteristics, procedural details, and follow-up outcomes were compared between the paroxysmal and non-paroxysmal cohorts.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 6,531 young patients with AF were included in the final analysis, with an average age of 37.7 ± 5.5 years, 77.1% were male, and 65.2% with paroxysmal AF. The primary comorbidities were hypertension (16.2%), heart failure (8.4%), valvular heart disease (3.5%), diabetes mellitus (3.2%), peripheral arterial disease (2.8%), stroke/transient ischemic attack (2.5%), and cardiomyopathy (2.2%). Following CA, the recurrence rate of AF post-CA was 14.4% across the entire cohort, with a lower recurrence rate in the paroxysmal AF group compared to the non-paroxysmal AF group (10.6% vs. 19.7%, <i>p</i> < 0.001). Non-paroxysmal AF (HR 2.34, 95% CI 1.62 to 3.36, <i>p</i> < 0.001) and hypertension (HR 1.69, 95% CI 1.09 to 2.63, <i>p</i> = 0.019) were identified as independent predictors for AF recurrence.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Young AF patients who undergo CA exhibit a low recurrence rate and a notable improvement in symptoms post-CA. Non-paroxysmal AF and hypertension emerge as primary contributors to AF recurrence following CA in this population.</p>\n </section>\n </div>","PeriodicalId":10201,"journal":{"name":"Clinical Cardiology","volume":"48 5","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.70144","citationCount":"0","resultStr":"{\"title\":\"Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation\",\"authors\":\"Xuewen Wang, Qiqi Cao, Tao Liu, Fan Zhang, Shujuan Zhang, Shaobo Shi, Qingyan Zhao, He Huang, Congxin Huang\",\"doi\":\"10.1002/clc.70144\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Data concerning young patients with atrial fibrillation (AF) are currently limited.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Hypothesis</h3>\\n \\n <p>This study aimed to assess the clinical characteristics and risk factors for AF recurrence in young patients following catheter ablation (CA).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>All AF patients aged ≤ 45 years who underwent CA were identified from the China Atrial Fibrillation Center database between September 2018 and September 2023. Baseline clinical characteristics, procedural details, and follow-up outcomes were compared between the paroxysmal and non-paroxysmal cohorts.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 6,531 young patients with AF were included in the final analysis, with an average age of 37.7 ± 5.5 years, 77.1% were male, and 65.2% with paroxysmal AF. The primary comorbidities were hypertension (16.2%), heart failure (8.4%), valvular heart disease (3.5%), diabetes mellitus (3.2%), peripheral arterial disease (2.8%), stroke/transient ischemic attack (2.5%), and cardiomyopathy (2.2%). Following CA, the recurrence rate of AF post-CA was 14.4% across the entire cohort, with a lower recurrence rate in the paroxysmal AF group compared to the non-paroxysmal AF group (10.6% vs. 19.7%, <i>p</i> < 0.001). Non-paroxysmal AF (HR 2.34, 95% CI 1.62 to 3.36, <i>p</i> < 0.001) and hypertension (HR 1.69, 95% CI 1.09 to 2.63, <i>p</i> = 0.019) were identified as independent predictors for AF recurrence.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Young AF patients who undergo CA exhibit a low recurrence rate and a notable improvement in symptoms post-CA. Non-paroxysmal AF and hypertension emerge as primary contributors to AF recurrence following CA in this population.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10201,\"journal\":{\"name\":\"Clinical Cardiology\",\"volume\":\"48 5\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.70144\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/clc.70144\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.70144","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景目前关于年轻心房颤动(AF)患者的资料有限。本研究旨在评估年轻患者导管消融(CA)后房颤复发的临床特征和危险因素。方法从2018年9月至2023年9月的中国心房颤动中心数据库中确定所有年龄≤45岁的房颤患者。基线临床特征、手术细节和随访结果在阵发性和非阵发性队列之间进行比较。结果共纳入年轻房颤患者6531例,平均年龄37.7±5.5岁,男性占77.1%,阵发性房颤占65.2%。主要合并症为高血压(16.2%)、心力衰竭(8.4%)、瓣膜性心脏病(3.5%)、糖尿病(3.2%)、外周动脉疾病(2.8%)、卒中/短暂性脑缺血发作(2.5%)、心肌病(2.2%)。在整个队列中,CA后AF复发率为14.4%,阵发性AF组的复发率低于非阵发性AF组(10.6%比19.7%,p < 0.001)。非阵发性房颤(HR 2.34, 95% CI 1.62 ~ 3.36, p < 0.001)和高血压(HR 1.69, 95% CI 1.09 ~ 2.63, p = 0.019)被确定为房颤复发的独立预测因子。结论年轻房颤患者行CA术后复发率低,症状明显改善。在这一人群中,非阵发性房颤和高血压是房颤复发的主要原因。
Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation
Background
Data concerning young patients with atrial fibrillation (AF) are currently limited.
Hypothesis
This study aimed to assess the clinical characteristics and risk factors for AF recurrence in young patients following catheter ablation (CA).
Methods
All AF patients aged ≤ 45 years who underwent CA were identified from the China Atrial Fibrillation Center database between September 2018 and September 2023. Baseline clinical characteristics, procedural details, and follow-up outcomes were compared between the paroxysmal and non-paroxysmal cohorts.
Results
A total of 6,531 young patients with AF were included in the final analysis, with an average age of 37.7 ± 5.5 years, 77.1% were male, and 65.2% with paroxysmal AF. The primary comorbidities were hypertension (16.2%), heart failure (8.4%), valvular heart disease (3.5%), diabetes mellitus (3.2%), peripheral arterial disease (2.8%), stroke/transient ischemic attack (2.5%), and cardiomyopathy (2.2%). Following CA, the recurrence rate of AF post-CA was 14.4% across the entire cohort, with a lower recurrence rate in the paroxysmal AF group compared to the non-paroxysmal AF group (10.6% vs. 19.7%, p < 0.001). Non-paroxysmal AF (HR 2.34, 95% CI 1.62 to 3.36, p < 0.001) and hypertension (HR 1.69, 95% CI 1.09 to 2.63, p = 0.019) were identified as independent predictors for AF recurrence.
Conclusion
Young AF patients who undergo CA exhibit a low recurrence rate and a notable improvement in symptoms post-CA. Non-paroxysmal AF and hypertension emerge as primary contributors to AF recurrence following CA in this population.
期刊介绍:
Clinical Cardiology provides a fully Gold Open Access forum for the publication of original clinical research, as well as brief reviews of diagnostic and therapeutic issues in cardiovascular medicine and cardiovascular surgery.
The journal includes Clinical Investigations, Reviews, free standing editorials and commentaries, and bonus online-only content.
The journal also publishes supplements, Expert Panel Discussions, sponsored clinical Reviews, Trial Designs, and Quality and Outcomes.